BPC-157 + TB-500 is a synergistic peptide combination formulated for the investigation of integrated tissue repair and regenerative signaling. BPC-157 (Body Protection Compound-157) is a pentadecapeptide known for its role in upregulating vascular endothelial growth factor (VEGF) and modulating the nitric oxide (NO) system to facilitate angiogenesis. TB-500 is a synthetic heptapeptide fragment of Thymosin Beta-4 that promotes cellular migration and proliferation by binding to G-actin. While BPC-157 is often studied for its localized cytoprotective effects and tendon-to-bone healing, TB-500 is investigated for its systemic ability to facilitate cell movement to injury sites. Research applications focus on the combined modulation of the extracellular matrix (ECM) and the acceleration of recovery in musculoskeletal injury models.
All products currently listed on this site are for research purposes only.